Limosilactobacillus reuteri Y15 modulated the colonic microbiota, counteracting cisplatin-induced dysbiosis in mice.
收藏NIAID Data Ecosystem2026-05-02 收录
官方服务：
资源简介：
Administration of LRY15 rebalanced the gut microbiota, restoring diversity and enriching beneficial genera (Lactobacillus, Bifidobacterium, Limosilactobacillus), thereby mitigating cisplatin-induced dysbiosis.
创建时间：
2025-08-27
